Recombinant human follicle-stimulating hormone versus urinary-derived human menopausal gonadotropin for controlled ovarian stimulation: the science and art of assisted reproductive technologies
- PMID: 14607556
- DOI: 10.1016/s0015-0282(03)02186-1
Recombinant human follicle-stimulating hormone versus urinary-derived human menopausal gonadotropin for controlled ovarian stimulation: the science and art of assisted reproductive technologies
Similar articles
-
Human menopausal gonadotropin and recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles.Fertil Steril. 2003 Nov;80(5):1121-2. doi: 10.1016/s0015-0282(03)02190-3. Fertil Steril. 2003. PMID: 14607560 No abstract available.
-
Methodologic pitfalls in assessing the efficacy of recombinant follicle-stimulating hormone versus human menopausal gonadotropin in assisted reproduction.Fertil Steril. 2003 Nov;80(5):1100-4. doi: 10.1016/s0015-0282(03)02193-9. Fertil Steril. 2003. PMID: 14607555 No abstract available.
-
Effectiveness of human menopausal gonadotropin versus recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles: a meta-analysis.Fertil Steril. 2003 Nov;80(5):1086-93. doi: 10.1016/s0015-0282(03)02187-3. Fertil Steril. 2003. PMID: 14607553
-
Choice of ovarian stimulation regimens in assisted reproduction: finding the thread in the gonadotropin maze.Fertil Steril. 2003 Nov;80(5):1114-6. doi: 10.1016/s0015-0282(03)02192-7. Fertil Steril. 2003. PMID: 14607558 Review. No abstract available.
-
Follicle-stimulating hormone in clinical practice: an update.Treat Endocrinol. 2004;3(3):161-71. doi: 10.2165/00024677-200403030-00004. Treat Endocrinol. 2004. PMID: 16026112 Review.
Cited by
-
Risk of breast cancer in assisted reproduction technology: a systematic review and meta-analysis protocol.Int J Surg Protoc. 2024 Oct 24;29(1):1-5. doi: 10.1097/SP9.0000000000000032. eCollection 2025 Dec 21. Int J Surg Protoc. 2024. PMID: 40453189 Free PMC article.
-
Conception and Concern: A Review of Breast Cancer Risk in Assisted Reproductive Technology.Int J Biol Sci. 2025 Mar 24;21(6):2647-2671. doi: 10.7150/ijbs.105357. eCollection 2025. Int J Biol Sci. 2025. PMID: 40303287 Free PMC article. Review.
-
Safety of drugs used in assisted reproduction techniques.Drug Saf. 2005;28(6):513-28. doi: 10.2165/00002018-200528060-00004. Drug Saf. 2005. PMID: 15924504 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical